Endocrinology
News
A third discontinuing levothyroxine have normal thyroid levels
Those with overt hypothyroidism are less likely to remain euthyroid than patients with subclinical disease, but many wind up restarting treatment...
News
Protecting patients with diabetes from impact of COVID-19
News
Further warning on SGLT2 inhibitor use and DKA risk in COVID-19
Five new cases of euglycemic diabetic ketoacidosis seen in T2D patients with acute COVID-19 illness.
News
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
Together, four “easily measured” biomarkers predicted 5-year heart failure risk in patients with diabetes or prediabetes, potentially identifying...
FDA/CDC
FDA okays first generic injected glucagon for hypoglycemia
The new generic will have the advantage of lower cost.
News
Sac/val heart failure benefit extends to diabetes patients
Sacubitril/valsartan had a similar effect on reverse cardiac remodeling for heart failure and reduced ejection fraction regardless of diabetes...
FDA/CDC
FDA approves liraglutide for adolescents with obesity
News
To D or not to D? Vitamin D doesn’t reduce falls in older adults
A study of wide-ranging vitamin D dosing finds no reduction in risk of falls, while high doses may even increase risk. But editorialist says check...
News
Blood glucose on admission predicts COVID-19 severity in all
Those with abnormally high glucose levels were more than twice as likely to die from the virus than were those with normal readings.